Theratechnologies is a Montreal biopharmaceutical company focused on specialized therapies in HIV and related unmet medical needs. Public company materials note that it commercializes two medicines in HIV and continues to advance pipeline and partnering activities. More recent updates also reference licensed metabolic disease assets intended for the Canadian market.